Your browser doesn't support javascript.
loading
Lethal aplastic anemia caused by dual immune checkpoint blockade in metastatic melanoma.
Helgadottir, H; Kis, L; Ljungman, P; Larkin, J; Kefford, R; Ascierto, P A; Hansson, J; Masucci, G.
Afiliação
  • Helgadottir H; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital.
  • Kis L; Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital.
  • Ljungman P; Departments of Allogeneic Stem Cell Transplantation and Hematology, Karolinska University Hospital.
  • Larkin J; Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Kefford R; Melanoma Unit, Royal Marsden NHS Foundation Trust, London.
  • Ascierto PA; Royal Marsden Hospital, London, UK.
  • Hansson J; Westmead Hospital, Melanoma Institute Australia and Macquarie University, Sydney, Australia.
  • Masucci G; Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Naples, Italy.
Ann Oncol ; 28(7): 1672-1673, 2017 07 01.
Article em En | MEDLINE | ID: mdl-28407116
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Anemia Aplástica / Melanoma Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Anemia Aplástica / Melanoma Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article